Back

Early epstein–barr virus–driven immune dysregulation after cardiac transplantation in trisomy 21 resulting in post-transplant lymphoproliferative disorder and haemophagocytic lymphohistiocytosis

31 August 2026 (08:30 - 08:45)
Organised by: Logo
Congress Presentation Part of: When the heart reveals systemic disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Mohammed Aljaafari

Western University, London (Canada)

3 More presentations in this session

Presentation thumbnail
Rare presentation of asymptomatic left ventricular pseudoaneurysm in a patient with well-controlled HIV infection
Doctor H. Septar (Bucharest, RO)
Presentation thumbnail
Multimodality imaging of intracardiac thrombosis and pulmonary artery aneurysms revealing vascular Behcet disease: a cautionary tale against premature anticoagulation
Doctor A. Idrissi Tlemcani (Tangier, MA)
Presentation thumbnail
Complete atrioventricular block as the presenting manifestation of Takayasu arteritis in a young adult
Doctor H. Kalkoul (Algiers, DZ)

Access the full session

Session thumbnail
When the heart reveals systemic disease

The Event

Event poster

ESC Congress 2026

31 August 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiogenic shock secondary to fulminant epstein–barr virus (EBV) myocarditis.
20 March 2026
thumbnail
Congress Session
Controversies in cardiac transplantation
19 May 2025
thumbnail
Congress Presentation
Early ECMO overcomes primary graft dysfunction after heart transplant
28 August 2020
thumbnail
Congress Session
Advanced heart failure – post transplant
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources